Apria, Inc. (APR): Price and Financial Metrics

Apria, Inc. (APR): $37.50

0.01 (+0.03%)

POWR Rating

Component Grades








APR Price/Volume Stats

Current price $37.50 52-week high $40.00
Prev. close $37.49 52-week low $22.36
Day low $37.49 Volume 585,400
Day high $37.51 Avg. volume 682,285
50-day MA $37.33 Dividend yield N/A
200-day MA $33.53 Market Cap 1.34B

APR Stock Price Chart Interactive Chart >

Apria, Inc. (APR) Company Bio

Apria, Inc. provides integrated home healthcare equipment and related services in the United States. The company offers home respiratory therapies, including the supply of stationary and portable home oxygen equipment, and non-invasive ventilators; obstructive sleep apnea therapy devices comprising continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services; and negative pressure wound therapy products. It also offers a range of home medical equipment and other products, and services for patients with home care needs; and clinical and administrative support services, and related products and supplies to patients. The company was incorporated in 2018 and is headquartered in Indianapolis, Indiana.

APR Latest News Stream

Event/Time News Detail
Loading, please wait...

APR Latest Social Stream

Loading social stream, please wait...

View Full APR Social Stream

Latest APR News From Around the Web

Below are the latest news stories about Apria Inc that investors may wish to consider to help them evaluate APR as an investment opportunity.

Apria Announces Expiration of Hart-Scott-Rodino Waiting Period

INDIANAPOLIS, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Apria, Inc. (the “Company” or “Apria”) (Nasdaq: APR), a leading provider of home medical equipment, supplies and related services in the United States, announced today that the waiting period has expired under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, in connection with its previously announced transaction with Owens & Minor, Inc. The closing of the transaction remains subject to approval by holders of a majority of the

Yahoo | February 24, 2022

Owens & Minor: Not A Minor Deal

Owens & Minor (OMI) has come to life during the pandemic. In October 2020, I concluded that shares looked a lot healthier, as shares had five-folded on the back of the pandemic. Stagnating sales, non-inspiring margins, and a debt-loaded balance sheet made investors very cautious, as the pandemic came at...

The Value Investor on Seeking Alpha | February 21, 2022

Is Apria (APR) Stock Outpacing Its Medical Peers This Year?

Here is how Apria (APR) and Actinium Pharmaceuticals (ATNM) have performed compared to their sector so far this year.

Yahoo | January 11, 2022

Company News for Jan 11, 2022

Companies in The News Are: CMC,AZZ,ZNGA,TTWO,APR,OMI

Yahoo | January 11, 2022

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

Welcome back, trader!

William White on InvestorPlace | January 10, 2022

Read More 'APR' Stories Here

APR Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year 32.74%
5-year N/A
2023 N/A
2022 0.00%
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!